cambridge's bluebird bio licenses delivery tech to novartis, gsk.
johns hopkins all children's hospital. [jim damaske |times]
.
yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital...